-Minyanville

Other Tools: Calculators | My Watchlist | My Portfolio

REPROS THERAPEUTICS Add to My Watchlist

(NSDQ: RPRX)

Detailed Quote

Last Price	0.72 (11.20.09 5:20 PM EST)
Change (%)	-0.02 (-2.39%)
Volume	613,889
Open	0.78
Previous Close	0.74
Day's Range	0.78 - 0.69
Bid / Ask	0.72 / 0.72

Intraday

3 Month

6 Month

1 Year

Average Volume	2,082,720	Shares Outstanding	15.18M
52-Week Range	0.65 - 13.94	Market Cap	10.9M
P/E Ratio	-0.3	Earnings Per Share	-2.07
Dividend	N/A	Yield	N/A

Symbol	Last	Change (%)
CPRX	0.70	+0.01 (+1.74%)
TSC	2.89	+0.00 (+0.00)
FONR	2.39	+0.09 (+3.91%)
BMOD	0.16	+0.00 (+0.65%)
ADMP	0.27	+0.01 (+3.92%)

Thu, Oct 08, 2009
	Drug stocks climb; Repros falls on stock deal Drug stocks climb in early trading as shares of Repros Therapeutics fall after it announces plans to sell 3.5 million of its common shares to a group of institutional investors for $1.27 a share. - MarketWatch
Tue, Sep 29, 2009
	Tuesday's biggest gaining and declining stocks Among the companies whose shares are expected to see active trade in Tuesday’s session are Big 5, Cell Therapeutics, Google, Nova Measuring Instruments, Starbucks, Sequenom, Siemens, Silicon Storage, and Warner Music Group. - MarketWatch
Mon, Aug 03, 2009
	Monday's biggest gaining and declining stocks Among the stocks expected to see active trading on Monday are Barclays, Barnes, Clorox, CNA Financial, Genzyme, HSBC, Humana, Loews, Marathon Oil, Nissan, Panasonic, Shire and Tyson Foods. - MarketWatch
	Tyson Foods, HSBC, Barclays and more in spotlight U.S. stock futures climbed on Monday, helped by improving manufacturing gauges across the globe ahead of the release of the U.S. report for July. - MarketWatch
Mon, Mar 16, 2009
	Updates, advisories and surprises A roundup of the latest corporate earnings reports and what companies are saying about future quarters. - MarketWatch
More Featured Content

Thu, Nov 12, 2009
	Repros Appoints Dr. Jaye Thompson to Board of Directors Nola E. Masterson Appointed As Board Chair - Business Wire
	Mirna Therapeutics Appoints Dr. Paul Lammers as President and CEO - Business Wire
Mon, Nov 09, 2009
	Repros to Appeal NASDAQ Delisting Notice - Business Wire
	Repros Therapeutics Inc. Reports Third Quarter 2009 Financial Results - Business Wire
Mon, Nov 02, 2009
	Fundamental and Technical Research for TKC, ACH, TEC, NAL, CTB and RPRX Posted on BenchmarkJournal.com Today NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Benchmark Journal. - Marketwire
More Press Releases

07/24/09		Business News Analyst Meeting Archive for RPRX
03/16/09		866-282-4865
02/17/09		Special Conference Roth 21st Annual OC Growth Stock Conference Archive for RPRX
02/09/09		Special Conference Eleventh Annual BIO CEO and Investor Conference Archive for RPRX
12/02/08		Special Conference Piper Jaffray Healthcare Conference Archive for RPRX

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Bio

Todd Harrison

Terry Woo

Kevin Depew

Jeff Macke

Andrew Jeffery

Jeffrey Cooper

Dr Janice Dorn

Allan Dodds Frank

John Mauldin

Smita Sadana